Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 232

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 232
---
 outstanding — diluted above as their effect would be anti -dilutive: •Outstanding an aggregate of 7,330,000 BLAC Warrants, comprised of 430,000 private placement warrants held by the Sponsor, BLAC’s Chief Financial Officer and two of BLAC’s former directors, and 6,900,000 public warrants. Each BLAC Warrant will be exercisable for one share of New OSR Holdings Common Stock at an initial exercise price of $11.50 per share (subject to adjustment in accordance with the Warrant Agreement) but do not become exercisable until 30 days after the Closing. •Up to 6,300,000shares of New OSR Holdings Common Stock issuable under the Omnibus Plan. 137

COMPARATIVE PER SHARE DATA

| Nine months ended September 30, 2024 Earnings (loss) per share, basic and diluted 
 Book value per share at September 30, 2024                                        |     | OSR holdings 
 Co., Ltd.    | (4.76 
 84.94 | ) |     | Bellevue      
 Life Sciences 
 Acquisition   
 Corp.         | (0.08 
 (2.67 | ) 
 ) |     | Pro Forma | (0.32 
 8.79  | ) |
|:----------------------------------------------------------------------------------|:----|:-------------|:------|:--|:----|:--------------|------:|:--|:----|:----------|:------|:--|
| Year Ended December 31, 2023 Earnings (loss) per share, basic and diluted         |     | $            | (6.25 | ) |     | $             |  0.05 |   |     | $         | (0.33 | ) |

138 THE BLAC STOCKHOLDERS’ MEETING General BLAC is furnishing this proxy statement/prospectus to its stockholders as part of the solicitation of proxies by the BLAC Board for use at the special meeting of BLAC to be held on February13, 2025, and at any adjournment or postponement thereof. This proxy statement/prospectus is first being furnished to BLAC’s stockholders on or about [•], 2025. Date and Time of the BLAC Stockholders’ Meeting The BLAC Stockholders’ Meeting will be held at 10900 NE 4 thStreet, Suite 2300, Bellevue, WA 98004